These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8357303)

  • 61. The tumor-inhibiting effect of isomeric dichloro(diphenylethylenediamine)platinum(II) complexes.
    Wappes B; Jennerwein M; von Angerer E; Engel J; Schönenberger H; Brunner H; Schmidt M; Berger M; Schmähl D; Seeber S
    J Cancer Res Clin Oncol; 1984; 107(1):15-20. PubMed ID: 6538199
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.
    Kaluderović GN; Schmidt H; Paschke R; Kalinowski B; Dietrich A; Mueller T; Steinborn D
    J Inorg Biochem; 2007 Mar; 101(3):543-9. PubMed ID: 17223197
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intraliposomal conversion of lipophilic cis-bis-carboxylato-trans-R,R-1,2-diaminocyclohexane-platinum (II) complexes into cis-bis-dichloro-trans-R,R-1,2-diaminocyclohexane-platinum (II).
    Han I; Khokhar AR; Perez-Soler R
    Cancer Chemother Pharmacol; 1996; 39(1-2):17-24. PubMed ID: 8995495
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Different response of murine and human mammary tumour models to a series of diastereoisomeric [1,2-bis(difluorophenyl) ethylenediamine]dichloroplatinum(II) complexes.
    Spruss T; Bernhardt G; Schickaneder E; Schönenberger H
    J Cancer Res Clin Oncol; 1991; 117(5):435-43. PubMed ID: 1890139
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In Vitro Anticancer Evaluation of Platinum(II/IV) Complexes with Diisoamyl Ester of (S,S)-ethylenediamine-N,N'-di-2-propanoic Acid.
    Zmejkovski BB; Pantelić N; Filipović L; Aranđelović S; Radulović S; Sabo TJ; Kaluđerović GN
    Anticancer Agents Med Chem; 2017; 17(8):1136-1143. PubMed ID: 27928952
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part II. Studies on the influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) on the specific immune defense in MXT-M-3,2 breast cancer bearing mice.
    Schlemmer R; Spruss T; Bernhardt G; Schönenberger H
    Arch Pharm (Weinheim); 2000 Dec; 333(12):397-403. PubMed ID: 11199469
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Third generation antitumor platinum(II) complexes of the [1-(fluoro/difluorophenyl)-2-phenylethylenediamine]platinum(II) type.
    Gust R; Schönenberger H
    Arch Pharm (Weinheim); 1995; 328(7-8):595-603. PubMed ID: 7492264
    [TBL] [Abstract][Full Text] [Related]  

  • 68. 1,3-Diphenylpropane-1,3-diamines, VI): DNA-interaction, estrogen receptor affinity, and cytostatic activity of 1,3-diphenylpropane-1,3-diamine-Pt(II) complexes.
    Kammermeier T; Wiegrebe W
    Arch Pharm (Weinheim); 1995 May; 328(5):409-15. PubMed ID: 7611836
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synthesis and evaluation of series of diazine-bridged dinuclear platinum(II) complexes through in vitro toxicity and molecular modeling: correlation between structure and activity of Pt(II) complexes.
    Senerovic L; Zivkovic MD; Veselinovic A; Pavic A; Djuran MI; Rajkovic S; Nikodinovic-Runic J
    J Med Chem; 2015 Feb; 58(3):1442-51. PubMed ID: 25551180
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bis-intercalative dinuclear platinum(II) 6-phenyl-2,2'-bipyridine complexes exhibit enhanced DNA affinity but similar cytotoxicity compared to the mononuclear unit.
    Chan HL; Ma DL; Yang M; Che CM
    J Biol Inorg Chem; 2003 Sep; 8(7):761-9. PubMed ID: 12884091
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Carrier mediated action of platinum complexes on estrogen receptor positive tumors.
    Knebel N; Schiller CD; Schneider MR; Schönenberger H; von Angerer E
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):293-9. PubMed ID: 2702983
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Morpholine or methylpiperazine and salicylaldimine based heteroleptic square planner platinum (II) complexes: In vitro anticancer study and growth retardation effect on E. coli.
    Rahman FU; Ali A; Khan IU; Duong HQ; Yu SB; Lin YJ; Wang H; Li ZT; Zhang DW
    Eur J Med Chem; 2017 May; 131():263-274. PubMed ID: 28334655
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antileukemic action of novel diamine Pt(II) halogenido complexes: Comparison of the representative novel Pt(II) with corresponding Pt(IV) complex.
    Misirlić Denčić S; Poljarević J; Isakovic AM; Marković I; Sabo TJ; Grgurić-Šipka S
    Chem Biol Drug Des; 2017 Aug; 90(2):262-271. PubMed ID: 28102932
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Anticancer activity in murine and human tumor cell lines of bis(platinum) complexes incorporating straight-chain aliphatic diamine linker groups.
    Kraker AJ; Hoeschele JD; Elliott WL; Showalter HD; Sercel AD; Farrell NP
    J Med Chem; 1992 Nov; 35(24):4526-32. PubMed ID: 1335074
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Labile Pd-sulphur and Pt-sulphur bonds in organometallic palladium and platinum complexes [(COD)M(alkyl)(S-ligand)]
    Lingen V; Lüning A; Krest A; Deacon GB; Schur J; Ott I; Pantenburg I; Meyer G; Klein A
    J Inorg Biochem; 2016 Dec; 165():119-127. PubMed ID: 27338203
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tumor inhibiting [1,2-bis(fluorophenyl)ethylenediamine]platinum(II) complexes. Part II: Biological evaluation-in vitro studies on the P 388 D1 leukemia cell line.
    Reile H; Müller R; Gust R; Laske R; Krischke W; Bernhardt G; Spruss T; Jennerwein M; Engel J; Seeber S
    Arch Pharm (Weinheim); 1990 Mar; 323(3):133-40. PubMed ID: 2344259
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Discrepancy between cytotoxicity, platinum accumulation, and DNA platination in MCF-7 breast cancer cells treated with diaqua (1,2-diphenylethylenediamine) platinum (II) sulfates and cisplatin.
    Lux F; Hollstein M; Reile H; Bernhardt G; Schönenberger H
    Biol Trace Elem Res; 1996; 53(1-3):113-28. PubMed ID: 8862742
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ring-substituted diaqua(1,2-diphenylethylenediamine)platinum(II) sulfate reacts with DNA through a dissociable complex.
    Bernges F; Holler E
    Eur J Biochem; 1992 Sep; 208(3):573-9. PubMed ID: 1396663
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Diamine ligand release from the cisplatin analogue [meso-1,2-bis(2,6-dichloro-4- hydroxyphenyl)ethylenediamine]dichloroplatinum(II) in cell culture medium.
    Bednarski PJ; Trümbach B; Kratochwil NA; Schönenberger H
    J Med Chem; 1992 Nov; 35(23):4479-85. PubMed ID: 1447748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.